Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,817
Total Claims
$2.2M
Drug Cost
671
Beneficiaries
$3,249
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+177%
Cost per patient vs peers
$3,249 vs $1,174 avg
+179%
Brand preference vs peers
24.7% vs 8.9% avg
Brand vs Generic
Brand: 2,868 claims · $1.9M
Generic: 8,741 claims · $284K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 785 | $395K |
| Semaglutide | 98 | $123K |
| Diclofenac Epolamine | 154 | $121K |
| Denosumab | 61 | $105K |
| Sitagliptin Phos/Metformin Hcl | 153 | $101K |
| Dapagliflozin Propanediol | 128 | $93K |
| Romosozumab-Aqqg | 37 | $92K |
| Tenofovir Alafenamide | 50 | $86K |
| Empagliflozin | 104 | $84K |
| Linaclotide | 119 | $72K |
| Empagliflozin/Metformin Hcl | 65 | $64K |
| Sitagliptin Phosphate | 77 | $58K |
| Icosapent Ethyl | 122 | $40K |
| Fluticasone/Umeclidin/Vilanter | 44 | $36K |
| Apixaban | 53 | $32K |
Prescribing Profile
Patient Profile
74
Avg Age
51%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data